Previous studies have shown that JAK2/STAT5 pathway was constitutively activated by Bcr-Abl in CML, resulting in uncontrolled cell survival and proliferation [2]. This evidence concerns the gene JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive.